Onconova Therapeutics, Inc. 4
4 · Onconova Therapeutics, Inc. · Filed Oct 1, 2015
Insider Transaction Report
Form 4
MCKEARN THOMAS J
President, R&D
Transactions
- Award
Stock Option (right to purchase)
2015-09-25+37,500→ 37,500 totalExercise: $1.48Exp: 2025-09-25→ Common Stock (37,500 underlying)
Footnotes (1)
- [F1]These options vest over four years in 48 equal monthly installments.